REQUEST A DEMO
Total
USD $0.00
Search more companies

Audifarma S.A. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Audifarma S.A. Profile Updated: February 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Audifarma S.A. was born on August 26, 1996 in the city of Pereira. It is engaged in the wholesale and retail trade of medicinal pharmaceuticals, cosmetics and toiletries. The company is a comprehensive pharmaceutical manager, providing global solutions to clients with a greater scope to the efficient management of risk. Today Audifarma S.A has about 500 CAF distributed throughout the national territory, over 4,000 employees and has a name backed by 20 years of experience.

Headquarters
Calle 105 Nro. 14 140 Barrio Belmonte
Pereira; Risaralda;

Contact Details: Purchase the Audifarma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Audifarma S.A. report to view the information.
Outstanding Shares:
Purchase the Audifarma S.A. report to view the information.
Incorporation Date:
August 26, 1996
Key Executives
Purchase this report to view the information.
Legal Representative
Subsidiaries
Coomeva Entidad Promotora de Salud S A en Liquidacion
7.46%
Company Performance
Financial values in the chart are available after Audifarma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
19.53%
Total operating revenue
19.71%
Operating profit (EBIT)
79.36%
EBITDA
78.26%
Net Profit (Loss) for the Period
31.25%
Total assets
25%
Total equity
-19.13%
Operating Profit Margin (ROS)
1.74%
Net Profit Margin
0.12%
Return on Equity (ROE)
9.29%
Debt to Equity Ratio
146.31%
Quick Ratio
-0.25%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?